Morphological and biological heterogeneity of three tumorigenic cell lines derived from a single p53−/− osteoblast-like cell line, MMC2
- 1 August 2002
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 182 (2) , 203-211
- https://doi.org/10.1016/s0304-3835(02)00096-4
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 20 references indexed in Scilit:
- The Retinoblastoma Protein Acts as a Transcriptional Coactivator Required for Osteogenic DifferentiationMolecular Cell, 2001
- Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosisCancer, 1999
- p53 transactivity during in vitro osteoblast differentiation in a rat osteosarcoma cell lineMolecular Carcinogenesis, 1999
- Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study.Journal of Clinical Oncology, 1998
- Establishment of an osteoblast-like cell line, MMC2, from p53-deficient miceBone, 1997
- Differentiation induced by RB expression and apoptosis induced by p53 expression in an osteosarcoma cell lineOncogene, 1997
- Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53Published by Elsevier ,1992
- Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 allelesCell, 1992
- 10 Prognosis in Osteogenic SarcomaPublished by Wolters Kluwer Health ,1968
- Osteogenic SarcomaJournal of Bone and Joint Surgery, 1967